These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 17272820)

  • 1. Antibody and complement in transplant vasculopathy.
    Wehner J; Morrell CN; Reynolds T; Rodriguez ER; Baldwin WM
    Circ Res; 2007 Feb; 100(2):191-203. PubMed ID: 17272820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute rejection: culprit or coincidence in the pathogenesis of cardiac graft vascular disease?
    Hauptman PJ; Nakagawa T; Tanaka H; Libby P
    J Heart Lung Transplant; 1995; 14(6 Pt 2):S173-80. PubMed ID: 8719481
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of the antibody to vascular endothelial cells in hyperacute rejection in patients undergoing cardiac transplantation.
    Trento A; Hardesty RL; Griffith BP; Zerbe T; Kormos RL; Bahnson HT
    J Thorac Cardiovasc Surg; 1988 Jan; 95(1):37-41. PubMed ID: 2447445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Donor CD4 T cells contribute to cardiac allograft vasculopathy by providing help for autoantibody production.
    Win TS; Rehakova S; Negus MC; Saeb-Parsy K; Goddard M; Conlon TM; Bolton EM; Bradley JA; Pettigrew GJ
    Circ Heart Fail; 2009 Jul; 2(4):361-9. PubMed ID: 19808360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late onset antibody-mediated rejection and endothelial localization of vascular endothelial growth factor are associated with development of cardiac allograft vasculopathy.
    Bayliss J; Bailey M; Leet A; Stein AN; Thomson NM; McLean CA
    Transplantation; 2008 Oct; 86(7):991-7. PubMed ID: 18852667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donor-specific HLA alloantibodies: long-term impact on cardiac allograft vasculopathy and mortality after heart transplant.
    Kaczmarek I; Deutsch MA; Kauke T; Beiras-Fernandez A; Schmoeckel M; Vicol C; Sodian R; Reichart B; Spannagl M; Ueberfuhr P
    Exp Clin Transplant; 2008 Sep; 6(3):229-35. PubMed ID: 18954302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular abnormalities and cardiomyocyte lipofuscin deposits in endomyocardial biopsy specimens of heart transplant recipients: are they related to the development of cardiac allograft vasculopathy?
    Zakliczynski M; Nozynski J; Konecka-Mrowka D; Krynicka-Mazurek A; Swierad M; Maruszewski M; Przybylski R; Zembala M
    J Thorac Cardiovasc Surg; 2009 Jul; 138(1):215-21, 221.e1-3. PubMed ID: 19577082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of histoincompatibility in cardiac allograft vasculopathy.
    Costanzo MR
    J Heart Lung Transplant; 1995; 14(6 Pt 2):S180-4. PubMed ID: 8719482
    [No Abstract]   [Full Text] [Related]  

  • 9. The composition of ectopic lymphoid structures suggests involvement of a local immune response in cardiac allograft vasculopathy.
    Huibers MM; Gareau AJ; Vink A; Kruit R; Feringa H; Beerthuijzen JM; Siera-de Koning E; Peeters T; de Jonge N; de Weger RA; Lee TD
    J Heart Lung Transplant; 2015 May; 34(5):734-45. PubMed ID: 25655346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histologic findings proving the existence of humoral rejection in a cardiac allograft.
    Abrams J; Amir O; Etheridge WB; Frazier OH
    Cardiovasc Pathol; 2007; 16(1):38-42. PubMed ID: 17218213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AP-1 and STAT-1 decoy oligodeoxynucleotides attenuate transplant vasculopathy in rat cardiac allografts.
    Stadlbauer TH; Wagner AH; Hölschermann H; Fiedel S; Fingerhuth H; Tillmanns H; Bohle RM; Hecker M
    Cardiovasc Res; 2008 Sep; 79(4):698-705. PubMed ID: 18511434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laboratory-clinical correlates of time-associated lesions in the vascular immunopathology of human cardiac allografts.
    Faulk WP; Labarrere CA; Pitts D; Halbrook H
    J Heart Lung Transplant; 1993; 12(2):S125-34. PubMed ID: 8476882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contemporary concepts in noncellular rejection.
    Kobashigawa JA
    Heart Fail Clin; 2007 Jan; 3(1):11-5. PubMed ID: 17545005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quilty effect, acute cellular rejection, and transplant vasculopathy: still controversial.
    Hiemann NE; Hetzer R; Meyer R
    J Heart Lung Transplant; 2009 Nov; 28(11):1240. PubMed ID: 19783181
    [No Abstract]   [Full Text] [Related]  

  • 15. Cryopreservation alters antigenicity of allografts in a porcine model of transplant vasculopathy.
    Solanes N; Rigol M; Castellà M; Khabiri E; Ramírez J; Segalés J; Roqué M; Agustí E; Pérez-Villa F; Roig E; Pomar JL; Sanz G; Heras M
    Transplant Proc; 2004 Dec; 36(10):3288-94. PubMed ID: 15686747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a combined heart and carotid artery transplant model to investigate the impact of acute rejection on cardiac allograft vasculopathy.
    Soleimani B; Fu F; Lake P; Shi VC
    J Heart Lung Transplant; 2008 Apr; 27(4):450-6. PubMed ID: 18374883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alloantibody and complement promote T cell-mediated cardiac allograft vasculopathy through noncanonical nuclear factor-κB signaling in endothelial cells.
    Jane-Wit D; Manes TD; Yi T; Qin L; Clark P; Kirkiles-Smith NC; Abrahimi P; Devalliere J; Moeckel G; Kulkarni S; Tellides G; Pober JS
    Circulation; 2013 Dec; 128(23):2504-16. PubMed ID: 24045046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accelerated arteriosclerosis in heart transplant recipients is associated with a T-lymphocyte-mediated endothelialitis.
    Hruban RH; Beschorner WE; Baumgartner WA; Augustine SM; Ren H; Reitz BA; Hutchins GM
    Am J Pathol; 1990 Oct; 137(4):871-82. PubMed ID: 1699422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute antibody-mediated rejection of cardiac transplants.
    Reed EF; Demetris AJ; Hammond E; Itescu S; Kobashigawa JA; Reinsmoen NL; Rodriguez ER; Rose M; Stewart S; Suciu-Foca N; Zeevi A; Fishbein MC;
    J Heart Lung Transplant; 2006 Feb; 25(2):153-9. PubMed ID: 16446213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody-mediated rejection: treatment alternatives and outcomes.
    Singh N; Pirsch J; Samaniego M
    Transplant Rev (Orlando); 2009 Jan; 23(1):34-46. PubMed ID: 19027615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.